Quest PharmaTech (QPT) Stock Chart & Stock Price History C$0.04 -0.01 (-12.50%) As of 01:59 PM Eastern Add Compare Share Share Chart Stock AnalysisChartInsider TradesBuy This Stock Quest PharmaTech Stock Price Performance The Quest PharmaTech (QPT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 133.33%, with a year-to-date return of 16.67%. In the past month, the stock has decreased 22.22%, reflecting recent market activity. As of the latest close, Quest PharmaTech traded at C$0.04 with a market cap of C$6.77 million and volume of 1,010 shares. Five years ago, the stock traded at C$0.15, representing a 76.67% decrease over that period. At the time, it had a market cap of C$21.76 million and a volume of 5,500 shares. Receive QPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-12.50%1 Month Performance-22.22%3 Month Performance0.00%Year-To-Date Performance+16.67%1 Year Performance+133.33%5 Year Performance-76.67% QPT Stock Chart for Monday, August, 25, 2025 QPT Chart by TradingView Quest PharmaTech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025C$0.04C$0.04-12.50%C$0.04C$0.0425,000 shsC$5.92 million08/22/2025C$0.04C$0.04C$0.04C$0.041,010 shsC$6.77 million08/21/2025C$0.04C$0.04C$0.04C$0.041,010 shsC$6.77 million08/20/2025C$0.04C$0.04C$0.04C$0.041,010 shsC$6.77 million08/19/2025C$0.04C$0.04+14.29%C$0.04C$0.041,010 shsC$6.77 million08/18/2025C$0.04C$0.04C$0.04C$0.045,000 shsC$5.92 million08/15/2025C$0.04C$0.04C$0.04C$0.044,000 shsC$5.92 million08/14/2025C$0.04C$0.04C$0.04C$0.044,000 shsC$5.92 million08/13/2025C$0.04C$0.04C$0.04C$0.044,000 shsC$5.92 million08/12/2025C$0.04C$0.04C$0.04C$0.0418,000 shsC$5.92 million Get the Latest News and Ratings for QPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025C$0.05C$0.04-22.22%C$0.04C$0.0418,000 shsC$5.92 million08/08/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.61 million08/07/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.61 million08/06/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.61 million08/05/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.61 million08/04/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.61 million08/01/2025C$0.05C$0.05C$0.05C$0.051,000 shsC$7.61 million07/31/2025C$0.04C$0.05+12.50%C$0.05C$0.051,000 shsC$7.61 million07/30/2025C$0.04C$0.04C$0.04C$0.0453,000 shsC$6.77 million07/29/2025C$0.05C$0.04-11.11%C$0.04C$0.0453,000 shsC$6.77 million07/28/2025C$0.05C$0.05C$0.05C$0.051,150 shsC$7.61 million07/25/2025C$0.05C$0.05C$0.05C$0.055,000 shsC$7.61 million07/24/2025C$0.05C$0.05C$0.05C$0.0412,000 shsC$7.61 million Related Companies GSD Stock Chart RVX Stock Chart SBM Stock Chart HEM Stock Chart IOT Stock Chart KNE Stock Chart BCT Stock Chart FRX Stock Chart TH Stock Chart ONC Stock Chart Receive QPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:QPT) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest PharmaTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access